| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |